Beta

Spending
Congress
Stocks
Lobbying

Spending
Congress
Stocks
Lobbying

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Congress
Stocks
Lobbying

LD-2 disclosure · 1st Quarter - Report (No Activity)

INTERLEUKIN GENETICS

via HEALTHFUTURES, LLC

1st Quarter (Jan 1 - Mar 31) · 2010Posted Apr 8, 2010Filing document ↗LDA record ↗

Coverage · No income or expenses were reported on this filing.

Client

Name: INTERLEUKIN GENETICS
Description: Development of genetic tests
Location: Massachusetts · United States of America

Registrant

Firm: HEALTHFUTURES, LLC
Description: Government relations firm
Location: Washington, District of Columbia, United States of America

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.

INTERLEUKIN GENETICS — Lobbying — Receipts Report